292 related articles for article (PubMed ID: 25616920)
1. Prophylactic warfarin therapy after primary percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction.
Le May MR; Acharya S; Wells GA; Burwash I; Chong AY; So DY; Glover CA; Froeschl MPV; Hibbert B; Marquis JF; Dick A; Blondeau M; Bernick J; Labinaz M
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):155-162. PubMed ID: 25616920
[TBL] [Abstract][Full Text] [Related]
2. Outcomes and Prognostic Impact of Prophylactic Oral Anticoagulation in Anterior ST-Segment Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction.
Shavadia JS; Youngson E; Bainey KR; Bakal J; Welsh RC
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673899
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic warfarin post anterior ST-elevation myocardial infarction: A systematic review and meta-analysis.
Moulson N; LaHaye SA; Bertrand OF; MacHaalany J
Cardiovasc Revasc Med; 2017 Dec; 18(8):559-564. PubMed ID: 28501493
[TBL] [Abstract][Full Text] [Related]
4. Incidence and Predictors of Left Ventricular Thrombus After Primary Percutaneous Coronary Intervention for Anterior ST-Segment Elevation Myocardial Infarction.
Driesman A; Hyder O; Lang C; Stockwell P; Poppas A; Abbott JD
Clin Cardiol; 2015 Oct; 38(10):590-7. PubMed ID: 26417910
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies.
Bavishi C; Koulova A; Bangalore S; Sawant A; Chatterjee S; Ather S; Valencia J; Sarafoff N; Rubboli A; Airaksinen JK; Lip GY; Tamis-Holland JE
Catheter Cardiovasc Interv; 2016 Jul; 88(1):E12-22. PubMed ID: 26354765
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus After Acute Anterior Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Intervention.
Liang J; Wang Z; Zhou Y; Shen H; Chai M; Ma X; Han H; Shao Q; Li Q
Curr Vasc Pharmacol; 2022; 20(6):517-526. PubMed ID: 36200193
[TBL] [Abstract][Full Text] [Related]
7. Worsening atrioventricular conduction after hospital discharge in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the HORIZONS-AMI trial.
Kosmidou I; Redfors B; McAndrew T; Embacher M; Mehran R; Dizon JM; Ben-Yehuda O; Mintz GS; Stone GW
Coron Artery Dis; 2017 Nov; 28(7):550-556. PubMed ID: 28644212
[TBL] [Abstract][Full Text] [Related]
8. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
Saltzman AJ; Stone GW; Claessen BE; Narula A; Leon-Reyes S; Weisz G; Brodie B; Witzenbichler B; Guagliumi G; Kornowski R; Dudek D; Metzger DC; Lansky AJ; Nikolsky E; Dangas GD; Mehran R
JACC Cardiovasc Interv; 2011 Sep; 4(9):1011-9. PubMed ID: 21939942
[TBL] [Abstract][Full Text] [Related]
9. Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
Hess CN; Peterson ED; Peng SA; de Lemos JA; Fosbol EL; Thomas L; Bhatt DL; Saucedo JF; Wang TY
J Am Coll Cardiol; 2015 Aug; 66(6):616-27. PubMed ID: 26248987
[TBL] [Abstract][Full Text] [Related]
10. Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
Kang DO; Yu CW; Kim HD; Cho JY; Joo HJ; Choi RK; Park JS; Lee HJ; Kim JS; Park JH; Hong SJ; Lim DS
Coron Artery Dis; 2015 Aug; 26(5):372-80. PubMed ID: 25768244
[TBL] [Abstract][Full Text] [Related]
11. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW
Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052
[TBL] [Abstract][Full Text] [Related]
12. Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial.
Sanborn TA; Tomey MI; Mehran R; Généreux P; Witzenbichler B; Brener SJ; Kirtane AJ; McAndrew TC; Kornowski R; Dudek D; Nikolsky E; Stone GW
Catheter Cardiovasc Interv; 2015 Feb; 85(3):371-9. PubMed ID: 25179260
[TBL] [Abstract][Full Text] [Related]
13. Bivalirudin for primary percutaneous coronary interventions: outcome assessment in the Ottawa STEMI registry.
Hibbert B; MacDougall A; Labinaz M; O'Brien ER; So DY; Dick A; Glover C; Froeschl M; Marquis JF; Wells GA; Blondeau M; Le May MR
Circ Cardiovasc Interv; 2012 Dec; 5(6):805-12. PubMed ID: 23149331
[TBL] [Abstract][Full Text] [Related]
14. Impact of delay to reperfusion on reperfusion success, infarct size, and clinical outcomes in patients with ST-segment elevation myocardial infarction: the INFUSE-AMI Trial (INFUSE-Anterior Myocardial Infarction).
Guerchicoff A; Brener SJ; Maehara A; Witzenbichler B; Fahy M; Xu K; Gersh BJ; Mehran R; Gibson CM; Stone GW
JACC Cardiovasc Interv; 2014 Jul; 7(7):733-40. PubMed ID: 25060015
[TBL] [Abstract][Full Text] [Related]
15. Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysis.
Bulluck H; Chan MHH; Paradies V; Yellon RL; Ho HH; Chan MY; Chin CWL; Tan JW; Hausenloy DJ
J Cardiovasc Magn Reson; 2018 Nov; 20(1):72. PubMed ID: 30404623
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of a Pharmacoinvasive Strategy in ST-Segment Elevation Myocardial Infarction: A Patient Population Study Comparing a Pharmacoinvasive Strategy With a Primary Percutaneous Coronary Intervention Strategy Within a Regional System.
Rashid MK; Guron N; Bernick J; Wells GA; Blondeau M; Chong AY; Dick A; Froeschl MPV; Glover CA; Hibbert B; Labinaz M; Marquis JF; Osborne C; So DY; Le May MR
JACC Cardiovasc Interv; 2016 Oct; 9(19):2014-2020. PubMed ID: 27712737
[TBL] [Abstract][Full Text] [Related]
17. Effect of sex on recovery of ejection fraction in patients with anterior ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Guo RW; Yang LX; Liu B; Qi F; Wang XM; Guo CM; Zhang W
Coron Artery Dis; 2014 Mar; 25(2):133-7. PubMed ID: 24253292
[TBL] [Abstract][Full Text] [Related]
18. Incidence and outcomes of early left ventricular thrombus following ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Khoury S; Carmon S; Margolis G; Keren G; Shacham Y
Clin Res Cardiol; 2017 Sep; 106(9):695-701. PubMed ID: 28396990
[TBL] [Abstract][Full Text] [Related]
19. Outcomes in diabetic patients undergoing primary percutaneous coronary intervention for acute anterior myocardial infarction: results from the INFUSE-AMI study.
Sanidas EA; Brener SJ; Maehara A; Généreux P; Witzenbichler B; El-Omar M; Fahy M; Mehran R; Gibson CM; Stone GW
Catheter Cardiovasc Interv; 2014 Apr; 83(5):704-10. PubMed ID: 24030863
[TBL] [Abstract][Full Text] [Related]
20. Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial.
Brener SJ; Maehara A; Dizon JM; Fahy M; Witzenbichler B; Parise H; El-Omar M; Dambrink JH; Mehran R; Oldroyd K; Gibson CM; Stone GW
JACC Cardiovasc Interv; 2013 Jul; 6(7):718-24. PubMed ID: 23866184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
